Dean Paranicas, CEO and president of the HealthCare Institute of New Jersey, isn’t just another state trade organization leader. Given that at least 11 of the
A new report from TEConomy Partners found that the biopharmaceutical industry supports over four million U.S. jobs and over $1.1 trillion in economic output. The biopharmaceutical
$166 billion in discounts intended for patients goes to middlemen New Brunswick, Jan. 29, 2020 ― An important new study sheds light on the dynamics
Although New Jersey’s biopharmaceutical sector opposed H.R. 3, we share its overriding goal – to ensure that patients can access the treatments and cures that
From NJBIZ: The history of manufacturing in New Jersey is the history of manufacturing in America. Historians can trace the birth of the country’s political
HINJ President and Chief Executive Officer Dean J. Paranicas has issued the following statement about the full repeal of the medical device excise tax: “Patients,
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
HealthCare Institute of New Jersey (HINJ)
222 W. State Street
Suite 302
Trenton, NJ 08608
Phone: 732-729-9619
©2023. HealthCare Institute of New Jersey (HINJ). All rights reserved.